Source
Amyloidosis News Today
An artificial intelligence (AI) model that analyzes the results of echocardiograms may help predict the likelihood of transthyretin amyloid cardiomyopathy (ATTR-CM) in people at high risk for the condition, a study suggested.
The model, AI-Echo, showed superior diagnostic potential than an AI model based on data from electrocardiograms (ECGs) and a clinical ATTR-CM score, which accounts for six demographic, clinical, and echo-based factors.
If validated, AI-Echo could help with ATTR-CM diagnosis, potentially allowing doctors to avoid unnecessary diagnostic procedures in some cases.
News Url